Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New findings in the area of breast cancer described
March 17th, 2005
Investigators in the United States, Belgium and France have published new breast cancer data. Study 1: Scientists have characterized a novel anti-aromatase coumarin derivative. According to recent research from the United States, "Estrogen stimulates the proliferation of estrogen receptor (ER)-positive breast cancer cells. Aromatase is the enzyme responsible for the conversion of androgens into estrogens, and synthetic aromatase inhibitors such as letrozole, anastrozole, and exemestane have proven to be effective endocrine regimens for ER-positive breast cancer. In a recent study, we have found that 4-benzyl-3(4'-chlorophenyl)-7-methoxycoumarin is a...
Source: Women's Health Weekly (2005-03-17)
|
